Searchable abstracts of presentations at key conferences in endocrinology

ea0011p492 | Endocrine tumours and neoplasia | ECE2006

PTTG binding factor (PBF) can transform cells independently of interaction with PTTG

Stratford AL , Boelaert K , Kim DS , Franklyn JA , McCabe CJ

We have previously shown PTTG and PBF to be over-expressed in differentiated thyroid cancer and to be prognostic indicators for recurrence. Subsequently we reported PBF to be a transforming gene in vitro and tumourigenic in vivo. Since over-expression of PTTG results in the same findings, we examined whether PBF-induced tumourigenesis was an independent effect, or else a result of increased PTTG activity. Two HA-tagged mutants of PBF were generated, firstly subst...

ea0011oc62 | ThyroidOC57 British Thyroid Association Award | ECE2006

The role of the thyroid hormone transporter monocarboxylate transporter 8 (MCT8) in fetal brain development

James SR , McCabe CJ , Smith VE , Chan SY , Barrett TG , Franklyn JA , Kilby MD

Thyroid hormones play a major role in the metabolic function of mammalian cells and are of particular importance in the development of the fetal brain. The MCT8 gene has recently been shown to encode an active and specific thyroid hormone transporter. Recent reports have identified mutations in the MCT8 gene in several unrelated boys presenting with severe X-linked psychomotor retardation and elevated serum T3.Ontogeny of mRNA encoding MCT8 was examined ...

ea0011p330 | Diabetes, metabolism and cardiovascular | ECE2006

How does glucose insulin potassium improve haemodynamic performance? Evidence for beta-adrenoreceptor and sarcoplasmic reticulum calcium ATPase up-regulation

Ranasinghe AM , Quinn DW , McCabe CJ , Pagano D , Franklyn JA , Bonser RS

Objectives: Glucose insulin potassium (GIK) improves haemodynamic performance following coronary artery bypass graft surgery (CABG). We postulated that this might be secondary to beta-1 adrenergic receptor (ADRB1) up-regulation and changes in myocyte calcium handling.Methods: We performed a randomised double-blind placebo-controlled trial on patients undergoing first time elective/urgent on-pump CABG (LREC approval obtained). A cohort of 48 patients rand...

ea0011p487 | Endocrine tumours and neoplasia | ECE2006

PTTG promotes a novel VEGF-KDR-ID3 autocrine mitogenic pathway in thyroid cancer

Kim DS , Buchanan MA , Stratford AL , Susarla R , Watkinson JC , Eggo MC , Franklyn JA , McCabe CJ

VEGF exerts its effects by binding to two tyrosine kinase receptors, KDR and VEGFR1. KDR is critical for transmitting signals for proliferation and migration of endothelial cells but is also expressed in several non-endothelial cells, and is elevated in some human tumour cells. We investigated KDR expression in human thyroid epithelial cells in vitro and thyroid cancers compared with normal thyroid samples examined ex vivo. Expression of KDR was demonstrated usin...

ea0011p561 | Growth and development | ECE2006

RAD21-dependent effects of securin/PTTG and separase on fetal neuronal NT2 cells

Pemberton HN , Boelaert K , Kim DS , Chan SY , Kilby MD , Franklyn JA , McCabe CJ

During the metaphase to anaphase transition of mitosis, destruction of the human securin, pituitary tumor-transforming gene (PTTG), and subsequent activation of the cysteine endopeptidase separase, leads to the cleavage of RAD21, a component protein of the cohesin complex. The developing fetal brain has rapidly proliferating neuronal cells, whilst adult neurons no longer proliferate and are maintained in G0 status of the cell cycle. We have previously investigated the expressi...

ea0019p170 | Endocrine tumours and neoplasia | SFEBES2009

The influence of oestrogen on PBF expression, secretion and invasion in MCF7 cells

Watkins RJ , Read ML , Smith VE , Lewy G , Eggo MC , Loubiere LS , Vasilopoulou E , Boelaert K , Franklyn JA , McCabe CJ

Pituitary tumor transforming gene binding factor (PBF) is a relatively uncharacterized gene implicated in endocrine neoplasia. Given the presence of putative oestrogen response elements (ERE) in its promoter, we assessed PBF regulation by oestrogen. PBF mRNA expression was induced maximally at 48 h by 20 nM diethylstilbestrol in ERalpha-positive MCF-7 cells (2.1±0.1-fold, P<0.001, N=6). PBF protein expression levels were also significantly up-regulated b...

ea0019p201 | Growth and development | SFEBES2009

Monocarboxylate transporter 8 (MCT8) in human fetal central nervous system (CNS) development

Chan S-Y , Martin-Santos A , Loubiere LS , Gonzalez AM , Cox P , Logan A , McCabe CJ , Franklyn JA , Kilby MD

Mutations in the plasma membrane thyroid hormone (TH) transporter, MCT8, are associated with severe global neurological deficits accompanied by abnormal circulating TH levels. We have previously shown that MCT8 over-expression in human neuronal precursor cells (NT2) increases cellular T3 uptake and reduces proliferation.Objectives: To quantify and localise the expression of MCT8 in human fetal CNS and to investigate the role of MCT8 in NT2 neurodifferent...

ea0011p906 | Thyroid | ECE2006

Repression of the human NIS upstream enhancer (hNUE) by PTTG

Smith VE , Boelaert K , Stratford AL , James SR , Susarla R , Kogai T , Eggo MC , Franklyn JA , McCabe CJ

The sodium iodide symporter (NIS) mediates the uptake of iodide into thyroid follicular cells. The pituitary tumor transforming gene (PTTG) is a multifunctional oncogene which stimulates expression of fibroblast growth factor-2 (FGF-2) via the PTTG binding factor (PBF). PTTG, FGF-2 and PBF are all up-regulated in thyroid cancer. PTTG and FGF-2 inhibit NIS mRNA expression and iodide uptake in rat thyroid FRTL5 cells. We have shown previously that both PTTG and PBF repres...